Jefferies Reiterates Buy on Amgen, Maintains $310 Price Target
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Michael Yee has reiterated a 'Buy' rating on Amgen (NASDAQ:AMGN) and maintained a price target of $310.
October 12, 2023 | 7:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst has reiterated a 'Buy' rating on Amgen and maintained a price target of $310.
The reiteration of a 'Buy' rating by a reputable analyst like Michael Yee from Jefferies is a positive signal for Amgen. The maintained price target of $310 indicates that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100